The peripheral vascular stent market is expected to grow from USD 4.59 billion in 2025 to USD 9.55 billion by 2035. The market is poised to expand at a 7.6% CAGR during the forecast period. Growth is being driven by the rising global incidence of peripheral artery disease (PAD), driven by aging demographics, lifestyle factors, and increasing rates of diabetes and hypertension.
Peripheral vascular stents offer critical advantages including minimally invasive placement, improved vessel patency, and reduced restenosis rates. These benefits are driving their adoption across vascular surgeries, particularly in lower extremity revascularization procedures.
Additionally, increasing awareness about PAD treatment options and growing availability of advanced stent technologies are further supporting market growth. Hospitals and specialty clinics are also expanding their interventional capabilities, thereby creating sustained demand for innovative vascular stent solutions.
Product innovation and technological advancements are further accelerating market momentum. Leading manufacturers are investing in the development of drug-eluting and bioresorbable stents that improve long-term patient outcomes while reducing complication rates.
Advances in stent materials such as ultra-thin struts and enhanced polymer coatings are delivering better deliverability and flexibility, enabling clinicians to access complex and tortuous lesions. Bioabsorbable scaffolds, smart stent designs integrated with imaging markers, and AI-driven procedural guidance are reshaping clinical practices in vascular interventions.
As precision medicine gains traction, personalized stent solutions are also emerging, offering tailored treatment for complex PAD cases. These innovations are helping companies differentiate their offerings and meet evolving clinical needs across a broad spectrum of healthcare settings.
Moreover, the market is likely to benefit from evolving regulatory frameworks and growing emphasis on patient-centric outcomes. Agencies such as the USA FDA and European Medicines Agency (EMA) are streamlining pathways for innovative device approvals, while enforcing robust safety and post-market surveillance requirements.
Regulations such as the EU Medical Device Regulation (MDR) and USA Premarket Approval (PMA) processes are driving companies to demonstrate superior efficacy, long-term safety, and clinical value of new stent designs. As healthcare systems increasingly focus on value-based care and reimbursement models reward improved outcomes, the peripheral vascular stent market is likely to witness rising adoption of advanced stents that deliver both clinical and economic benefits across global markets.
| Metric | Value |
|---|---|
| Industry Size (2025E) | USD 4.59 billion |
| Industry Value (2035F) | USD 9.55 billion |
| CAGR (2025 to 2035) | 7.6% |
The market is segmented based on product type, artery type, end user, and region. By product type, the market is divided into self-expanding stents, balloon-expanding stents, covered stents, and drug-eluting stents. In terms of artery type, it is segmented into carotid artery, fem-pop artery, iliac artery, and infrapop artery.
Based on end user, the market is categorized into hospitals and ambulatory surgical centres/outpatients. Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, and the Middle East and Africa.
Self-expanding stents segment holds 53.1% market share in 2025. The drug-eluting stents segment is witnessing increasing demand due to their ability to reduce restenosis and improve long-term vascular outcomes, making them the preferred choice for complex peripheral artery disease interventions.
These stents release therapeutic agents that inhibit neointimal hyperplasia, improving vessel patency. Increasing adoption is driven by clinical trials supporting their efficacy in fem-pop and below-the-knee interventions, especially in aging populations with comorbidities like diabetes. Technological advancements, including next-generation bioresorbable polymers and tailored drug coatings, are further enhancing their market potential.
Self-expanding stents continue to dominate volume-wise due to their flexibility and ability to adapt to peripheral vessel anatomy. Balloon-expanding stents are preferred in cases requiring precise deployment and high radial strength, particularly in iliac arteries. Covered stents remain vital for complex lesions and aneurysm repair, offering protection against vessel rupture and perforation.
While each stent type has a defined clinical role, the accelerating demand for drug-eluting stents, backed by strong clinical data and improving reimbursement scenarios, is reshaping the competitive landscape of peripheral vascular interventions.
| Product Type | Share (2025) |
|---|---|
| Self-expanding Stents | 53.1% |
Iliac artery segment holds 48% market share in 2025. The fem-pop artery segment is witnessing strong demand growth, driven by the rising incidence of peripheral artery disease (PAD), particularly in the elderly and diabetic populations. The femoral-popliteal segment is highly susceptible to atherosclerotic plaque buildup, creating sustained demand for advanced stent solutions.
Recent innovations in stent flexibility, fracture resistance, and drug delivery are enabling better outcomes in this challenging arterial zone. Moreover, the shift toward minimally invasive endovascular procedures are promoting the use of drug-eluting stents and next-generation self-expanding devices in the fem-pop segment.
The carotid artery segment remains critical for stroke prevention, supported by steady demand for stenting as an alternative to carotid endarterectomy. Iliac artery interventions continue to see strong uptake, particularly in cases requiring high radial force and large-diameter stents.
The infrapop artery segment is growing steadily as well, driven by increasing clinical attention to below-the-knee revascularization in critical limb ischemia cases. Across all segments, fem-pop artery stents are emerging as the innovation focal point, driven by the complex biomechanics and high restenosis risks associated with this anatomical region.
| Artery Type | Share (2025) |
|---|---|
| Iliac Artery | 48% |
Ambulatory surgical centers/outpatients are projected to grow at the CAGR of 7.9% from 2025 to 2035. This trend is fueled by the healthcare industry's ongoing shift toward outpatient vascular interventions. ASCs offer cost-effective, patient-friendly alternatives to traditional hospital-based procedures.
Advances in device technology and post-procedure management are making same-day discharge increasingly viable for peripheral stenting. Additionally, favorable reimbursement policies and growing ASC networks across the USA and Europe are accelerating the transition of endovascular procedures to outpatient settings.
Hospitals, however, remain the primary treatment centers for complex peripheral interventions and emergency cases. They continue to dominate the market in terms of overall volume, owing to the availability of advanced imaging, hybrid ORs, and multidisciplinary vascular care teams. Hospitals also cater to high-risk patients who require comprehensive perioperative monitoring. While ASCs lead growth, the complementary roles of both settings are vital in broadening patient access to peripheral vascular stenting solutions.
| End User | CAGR (2025 to 2035) |
|---|---|
| Ambulatory Surgical Centers/Outpatients | 7.9% |
| Countries | Forecast CAGR (2025 to 2035) |
|---|---|
| The United States | 5.90% |
| The United Kingdom | 6.40% |
| GCC Countries | 7.60% |
| China | 10.30% |
| India | 7.10% |
The demand for peripheral vascular stents in the United States is estimated to assume a pace of 5.90% CAGR over the upcoming decade. The chief factor that is driving the United States market is the broad availability of newly approved drug-eluting stents across the country.
The United States market wields substantial power in North America as it stands at the forefront and determines the region’s growth. Fundamental drivers that are supporting the market’s expansion include the expanding geriatric population and the prevailing utilization of peripheral stent implants. Surging acceptance of minimally invasive procedures for cardiovascular disorders is another contributing factor.
The rising presence of peripheral vascular stent providers is compelling market growth. Additionally, the approval and early availability of the latest, technologically progressive stents have also transformed the peripheral vascular stents market landscape. These include bio-absorbable and drug-eluting stents.
The United Kingdom peripheral vascular stent market is projected to expand at a CAGR of 6.40% over the forecast period. The market is supposed to grow in the United Kingdom as a result of increasing studies to widen the scope of peripheral arterial disease treatment options.
For instance, in May 2025, BD, a prominent medical technology player, announced the first patient enrollment in the investigational device exemption (IDE) study called “AGILITY”. The study assesses the effectiveness and safety of the BD Vascular Covered Stent for the Peripheral Arterial Disease (PAD) treatment.
The company stated that the global, non-randomized, multi-center, prospective, single-arm AGILITY clinical study is expected to include 315 patients. The study encompasses 40 clinical study sites throughout Europe, the United States, New Zealand, and Australia.
The sale of peripheral vascular stent in India is expected to increase at a CAGR of 7.10% over the forecast period. The market is propelled by the expanding patient pool and increasing elderly population who are susceptible to chronic illnesses.
Surging adoption of peripheral angioplasty, the rising presence of cost-effective surgeries, and enhancing immunization access are some common contributory factors that are propelling market growth.
Indian players are actively contributing to the advancement of this industry. For example, Concept Medical Inc., an MNC for medical devices founded by Manish Doshi. The MNC made headlines with Concept Medical’s MagicTouch in a confluence of acclaimed Indian and foreign doctors which was held in Surat in January 2025. Concept Medical’s MagicTouch is the world’s first Sirolimus-coated balloon.
The product is becoming commercial just in time to offer a ray of hope for millions of people inflicted with peripheral vascular disease (PVD). In this confluence, doctors came together to discuss the latest advancements in vascular medicine, effective patient relief measures, and strategies for halting PVD development.
The peripheral vascular stent market in China is predicted to expand at an impressive CAGR of 10.30% over the forecast period. A growing patient base for people suffering from high-risk cardiovascular diseases is a key determiner for the use of stents to treat obstructive coronary diseases.
The primary strategy adopted by domestic players in China is the affordable cost of stents. Additionally, key players in the industry are persistently developing distinct and groundbreaking stent technologies to help them obtain a leading market position.
Biotronik had revealed in the historical period that its new Orsiro DES has gained approval for sale by the National Medical Products Administration in the country. This move means that the firm will be able to make the stent available for patients and medical practitioners in a matter of months.
The peripheral vascular stent market in GCC countries is expected to increase at 7.60% CAGR over the next decade. Poor knowledge about peripheral artery diseases (PAD) among the high-risk individuals residing in GCC countries is increasing the risk of PADs in these countries.
Industry participants are also using this knowledge gap to target their educational campaigns, especially among high-risk populations. Players are enhancing their portfolios by investing in new technologies. Furthermore, advancements supported by modern technologies are expected to introduce the latest trends in the market across GCC countries.
Biosensors, Abbott, Boston Scientific, Biotronik, Stryker, Medtronic, Terumo, and B. Braun are identified as powerful players in the peripheral vascular stent market. Their growth is stimulated by the increasing count of cardiovascular surgeries performed alongside minimally invasive techniques.
Medical equipment manufacturers are using market penetrative strategies to gain a large foothold in the industry. The launch of the self-expanding Eluvia drug-eluting stent (DES) system, in the historical period, is a top strategy adopted by market players. This launch served a double benefit as it helped the company extend its PAD portfolio as well as utilize a new drug-polymer combination for the sustained release of the drug paclitaxel.
In the quest to gain a larger foothold in the market, stent makers and medical device manufacturers are investing in research and innovations to elevate their portfolios. ETH Zurich researchers have released a new method to develop malleable microstructure production utilizing indirect 4-D printing.
This latest technology has the potential to develop malleable microstructure production utilizing indirect 4-D printing. Moreover, the government support for certain studied and analyzed product offerings is also encouraging players to expand in this market.
In emerging markets, stent manufacturers are acquiring and merging with other competing players to enhance their position.
| Attribute | Details |
|---|---|
| Current Total Market Size (2025) | USD 4.59 billion |
| Projected Market Size (2035) | USD 9.55 billion |
| CAGR (2025 to 2035) | 7.6% |
| Base Year for Estimation | 2024 |
| Historical Period | 2020 to 2024 |
| Projections Period | 2025 to 2035 |
| Report Parameter | Revenue in USD billion/volume in units |
| By Product Type | Self-Expanding Stents, Balloon-Expanding Stents, Covered Stents, and Drug-Eluting Stents |
| By Artery Type | Carotid Artery, Fem-Pop Artery, Iliac Artery, and Infrapop Artery |
| By End User | Hospitals and Ambulatory Surgical Centres/Outpatients |
| Regions Covered | North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, Middle East and Africa |
| Countries Covered | United States, United Kingdom, GCC Countries, China, India |
| Key Players | Medtronic Plc., Cardinal Health, Inc., B. Braun Melsungen AG, MicroPort Scientific Corporation, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Abbott Laboratories, W.L. Gore & Associates Inc., Cook Medical Inc. |
| Additional Attributes | Dollar sales by value, market share analysis by region, and country-wise analysis |
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Volume (Units) Forecast by Region, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by Product Type, 2019 to 2034
Table 4: Global Market Volume (Units) Forecast by Product Type, 2019 to 2034
Table 5: Global Market Value (US$ Million) Forecast by Artery Type, 2019 to 2034
Table 6: Global Market Volume (Units) Forecast by Artery Type, 2019 to 2034
Table 7: Global Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 8: Global Market Volume (Units) Forecast by End User, 2019 to 2034
Table 9: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 10: North America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 11: North America Market Value (US$ Million) Forecast by Product Type, 2019 to 2034
Table 12: North America Market Volume (Units) Forecast by Product Type, 2019 to 2034
Table 13: North America Market Value (US$ Million) Forecast by Artery Type, 2019 to 2034
Table 14: North America Market Volume (Units) Forecast by Artery Type, 2019 to 2034
Table 15: North America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 16: North America Market Volume (Units) Forecast by End User, 2019 to 2034
Table 17: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 18: Latin America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 19: Latin America Market Value (US$ Million) Forecast by Product Type, 2019 to 2034
Table 20: Latin America Market Volume (Units) Forecast by Product Type, 2019 to 2034
Table 21: Latin America Market Value (US$ Million) Forecast by Artery Type, 2019 to 2034
Table 22: Latin America Market Volume (Units) Forecast by Artery Type, 2019 to 2034
Table 23: Latin America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 24: Latin America Market Volume (Units) Forecast by End User, 2019 to 2034
Table 25: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 26: Western Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 27: Western Europe Market Value (US$ Million) Forecast by Product Type, 2019 to 2034
Table 28: Western Europe Market Volume (Units) Forecast by Product Type, 2019 to 2034
Table 29: Western Europe Market Value (US$ Million) Forecast by Artery Type, 2019 to 2034
Table 30: Western Europe Market Volume (Units) Forecast by Artery Type, 2019 to 2034
Table 31: Western Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 32: Western Europe Market Volume (Units) Forecast by End User, 2019 to 2034
Table 33: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 34: Eastern Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 35: Eastern Europe Market Value (US$ Million) Forecast by Product Type, 2019 to 2034
Table 36: Eastern Europe Market Volume (Units) Forecast by Product Type, 2019 to 2034
Table 37: Eastern Europe Market Value (US$ Million) Forecast by Artery Type, 2019 to 2034
Table 38: Eastern Europe Market Volume (Units) Forecast by Artery Type, 2019 to 2034
Table 39: Eastern Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 40: Eastern Europe Market Volume (Units) Forecast by End User, 2019 to 2034
Table 41: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 42: South Asia and Pacific Market Volume (Units) Forecast by Country, 2019 to 2034
Table 43: South Asia and Pacific Market Value (US$ Million) Forecast by Product Type, 2019 to 2034
Table 44: South Asia and Pacific Market Volume (Units) Forecast by Product Type, 2019 to 2034
Table 45: South Asia and Pacific Market Value (US$ Million) Forecast by Artery Type, 2019 to 2034
Table 46: South Asia and Pacific Market Volume (Units) Forecast by Artery Type, 2019 to 2034
Table 47: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 48: South Asia and Pacific Market Volume (Units) Forecast by End User, 2019 to 2034
Table 49: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 50: East Asia Market Volume (Units) Forecast by Country, 2019 to 2034
Table 51: East Asia Market Value (US$ Million) Forecast by Product Type, 2019 to 2034
Table 52: East Asia Market Volume (Units) Forecast by Product Type, 2019 to 2034
Table 53: East Asia Market Value (US$ Million) Forecast by Artery Type, 2019 to 2034
Table 54: East Asia Market Volume (Units) Forecast by Artery Type, 2019 to 2034
Table 55: East Asia Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 56: East Asia Market Volume (Units) Forecast by End User, 2019 to 2034
Table 57: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 58: Middle East and Africa Market Volume (Units) Forecast by Country, 2019 to 2034
Table 59: Middle East and Africa Market Value (US$ Million) Forecast by Product Type, 2019 to 2034
Table 60: Middle East and Africa Market Volume (Units) Forecast by Product Type, 2019 to 2034
Table 61: Middle East and Africa Market Value (US$ Million) Forecast by Artery Type, 2019 to 2034
Table 62: Middle East and Africa Market Volume (Units) Forecast by Artery Type, 2019 to 2034
Table 63: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 64: Middle East and Africa Market Volume (Units) Forecast by End User, 2019 to 2034
Figure 1: Global Market Value (US$ Million) by Product Type, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by Artery Type, 2024 to 2034
Figure 3: Global Market Value (US$ Million) by End User, 2024 to 2034
Figure 4: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 6: Global Market Volume (Units) Analysis by Region, 2019 to 2034
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 9: Global Market Value (US$ Million) Analysis by Product Type, 2019 to 2034
Figure 10: Global Market Volume (Units) Analysis by Product Type, 2019 to 2034
Figure 11: Global Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 12: Global Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 13: Global Market Value (US$ Million) Analysis by Artery Type, 2019 to 2034
Figure 14: Global Market Volume (Units) Analysis by Artery Type, 2019 to 2034
Figure 15: Global Market Value Share (%) and BPS Analysis by Artery Type, 2024 to 2034
Figure 16: Global Market Y-o-Y Growth (%) Projections by Artery Type, 2024 to 2034
Figure 17: Global Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 18: Global Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 21: Global Market Attractiveness by Product Type, 2024 to 2034
Figure 22: Global Market Attractiveness by Artery Type, 2024 to 2034
Figure 23: Global Market Attractiveness by End User, 2024 to 2034
Figure 24: Global Market Attractiveness by Region, 2024 to 2034
Figure 25: North America Market Value (US$ Million) by Product Type, 2024 to 2034
Figure 26: North America Market Value (US$ Million) by Artery Type, 2024 to 2034
Figure 27: North America Market Value (US$ Million) by End User, 2024 to 2034
Figure 28: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 29: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 30: North America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 31: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 32: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 33: North America Market Value (US$ Million) Analysis by Product Type, 2019 to 2034
Figure 34: North America Market Volume (Units) Analysis by Product Type, 2019 to 2034
Figure 35: North America Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 36: North America Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 37: North America Market Value (US$ Million) Analysis by Artery Type, 2019 to 2034
Figure 38: North America Market Volume (Units) Analysis by Artery Type, 2019 to 2034
Figure 39: North America Market Value Share (%) and BPS Analysis by Artery Type, 2024 to 2034
Figure 40: North America Market Y-o-Y Growth (%) Projections by Artery Type, 2024 to 2034
Figure 41: North America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 42: North America Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 43: North America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 44: North America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 45: North America Market Attractiveness by Product Type, 2024 to 2034
Figure 46: North America Market Attractiveness by Artery Type, 2024 to 2034
Figure 47: North America Market Attractiveness by End User, 2024 to 2034
Figure 48: North America Market Attractiveness by Country, 2024 to 2034
Figure 49: Latin America Market Value (US$ Million) by Product Type, 2024 to 2034
Figure 50: Latin America Market Value (US$ Million) by Artery Type, 2024 to 2034
Figure 51: Latin America Market Value (US$ Million) by End User, 2024 to 2034
Figure 52: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 53: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 54: Latin America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 55: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 57: Latin America Market Value (US$ Million) Analysis by Product Type, 2019 to 2034
Figure 58: Latin America Market Volume (Units) Analysis by Product Type, 2019 to 2034
Figure 59: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 60: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 61: Latin America Market Value (US$ Million) Analysis by Artery Type, 2019 to 2034
Figure 62: Latin America Market Volume (Units) Analysis by Artery Type, 2019 to 2034
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Artery Type, 2024 to 2034
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Artery Type, 2024 to 2034
Figure 65: Latin America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 66: Latin America Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 67: Latin America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 68: Latin America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 69: Latin America Market Attractiveness by Product Type, 2024 to 2034
Figure 70: Latin America Market Attractiveness by Artery Type, 2024 to 2034
Figure 71: Latin America Market Attractiveness by End User, 2024 to 2034
Figure 72: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 73: Western Europe Market Value (US$ Million) by Product Type, 2024 to 2034
Figure 74: Western Europe Market Value (US$ Million) by Artery Type, 2024 to 2034
Figure 75: Western Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 76: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 77: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 78: Western Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 79: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 80: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 81: Western Europe Market Value (US$ Million) Analysis by Product Type, 2019 to 2034
Figure 82: Western Europe Market Volume (Units) Analysis by Product Type, 2019 to 2034
Figure 83: Western Europe Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 84: Western Europe Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 85: Western Europe Market Value (US$ Million) Analysis by Artery Type, 2019 to 2034
Figure 86: Western Europe Market Volume (Units) Analysis by Artery Type, 2019 to 2034
Figure 87: Western Europe Market Value Share (%) and BPS Analysis by Artery Type, 2024 to 2034
Figure 88: Western Europe Market Y-o-Y Growth (%) Projections by Artery Type, 2024 to 2034
Figure 89: Western Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 90: Western Europe Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 91: Western Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 93: Western Europe Market Attractiveness by Product Type, 2024 to 2034
Figure 94: Western Europe Market Attractiveness by Artery Type, 2024 to 2034
Figure 95: Western Europe Market Attractiveness by End User, 2024 to 2034
Figure 96: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 97: Eastern Europe Market Value (US$ Million) by Product Type, 2024 to 2034
Figure 98: Eastern Europe Market Value (US$ Million) by Artery Type, 2024 to 2034
Figure 99: Eastern Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 100: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 101: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 102: Eastern Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 103: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 104: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 105: Eastern Europe Market Value (US$ Million) Analysis by Product Type, 2019 to 2034
Figure 106: Eastern Europe Market Volume (Units) Analysis by Product Type, 2019 to 2034
Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 109: Eastern Europe Market Value (US$ Million) Analysis by Artery Type, 2019 to 2034
Figure 110: Eastern Europe Market Volume (Units) Analysis by Artery Type, 2019 to 2034
Figure 111: Eastern Europe Market Value Share (%) and BPS Analysis by Artery Type, 2024 to 2034
Figure 112: Eastern Europe Market Y-o-Y Growth (%) Projections by Artery Type, 2024 to 2034
Figure 113: Eastern Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 114: Eastern Europe Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 115: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 116: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 117: Eastern Europe Market Attractiveness by Product Type, 2024 to 2034
Figure 118: Eastern Europe Market Attractiveness by Artery Type, 2024 to 2034
Figure 119: Eastern Europe Market Attractiveness by End User, 2024 to 2034
Figure 120: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 121: South Asia and Pacific Market Value (US$ Million) by Product Type, 2024 to 2034
Figure 122: South Asia and Pacific Market Value (US$ Million) by Artery Type, 2024 to 2034
Figure 123: South Asia and Pacific Market Value (US$ Million) by End User, 2024 to 2034
Figure 124: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 125: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 126: South Asia and Pacific Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 127: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 128: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 129: South Asia and Pacific Market Value (US$ Million) Analysis by Product Type, 2019 to 2034
Figure 130: South Asia and Pacific Market Volume (Units) Analysis by Product Type, 2019 to 2034
Figure 131: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 132: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 133: South Asia and Pacific Market Value (US$ Million) Analysis by Artery Type, 2019 to 2034
Figure 134: South Asia and Pacific Market Volume (Units) Analysis by Artery Type, 2019 to 2034
Figure 135: South Asia and Pacific Market Value Share (%) and BPS Analysis by Artery Type, 2024 to 2034
Figure 136: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Artery Type, 2024 to 2034
Figure 137: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 138: South Asia and Pacific Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 139: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 140: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 141: South Asia and Pacific Market Attractiveness by Product Type, 2024 to 2034
Figure 142: South Asia and Pacific Market Attractiveness by Artery Type, 2024 to 2034
Figure 143: South Asia and Pacific Market Attractiveness by End User, 2024 to 2034
Figure 144: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 145: East Asia Market Value (US$ Million) by Product Type, 2024 to 2034
Figure 146: East Asia Market Value (US$ Million) by Artery Type, 2024 to 2034
Figure 147: East Asia Market Value (US$ Million) by End User, 2024 to 2034
Figure 148: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 149: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 150: East Asia Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 151: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 152: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 153: East Asia Market Value (US$ Million) Analysis by Product Type, 2019 to 2034
Figure 154: East Asia Market Volume (Units) Analysis by Product Type, 2019 to 2034
Figure 155: East Asia Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 156: East Asia Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 157: East Asia Market Value (US$ Million) Analysis by Artery Type, 2019 to 2034
Figure 158: East Asia Market Volume (Units) Analysis by Artery Type, 2019 to 2034
Figure 159: East Asia Market Value Share (%) and BPS Analysis by Artery Type, 2024 to 2034
Figure 160: East Asia Market Y-o-Y Growth (%) Projections by Artery Type, 2024 to 2034
Figure 161: East Asia Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 162: East Asia Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 163: East Asia Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 164: East Asia Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 165: East Asia Market Attractiveness by Product Type, 2024 to 2034
Figure 166: East Asia Market Attractiveness by Artery Type, 2024 to 2034
Figure 167: East Asia Market Attractiveness by End User, 2024 to 2034
Figure 168: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 169: Middle East and Africa Market Value (US$ Million) by Product Type, 2024 to 2034
Figure 170: Middle East and Africa Market Value (US$ Million) by Artery Type, 2024 to 2034
Figure 171: Middle East and Africa Market Value (US$ Million) by End User, 2024 to 2034
Figure 172: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 173: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 174: Middle East and Africa Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 175: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 176: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 177: Middle East and Africa Market Value (US$ Million) Analysis by Product Type, 2019 to 2034
Figure 178: Middle East and Africa Market Volume (Units) Analysis by Product Type, 2019 to 2034
Figure 179: Middle East and Africa Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 180: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 181: Middle East and Africa Market Value (US$ Million) Analysis by Artery Type, 2019 to 2034
Figure 182: Middle East and Africa Market Volume (Units) Analysis by Artery Type, 2019 to 2034
Figure 183: Middle East and Africa Market Value Share (%) and BPS Analysis by Artery Type, 2024 to 2034
Figure 184: Middle East and Africa Market Y-o-Y Growth (%) Projections by Artery Type, 2024 to 2034
Figure 185: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 186: Middle East and Africa Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 187: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 188: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 189: Middle East and Africa Market Attractiveness by Product Type, 2024 to 2034
Figure 190: Middle East and Africa Market Attractiveness by Artery Type, 2024 to 2034
Figure 191: Middle East and Africa Market Attractiveness by End User, 2024 to 2034
Figure 192: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
The market is projected to reach USD 9.55 billion by 2035, growing from USD 4.59 billion in 2025, at a CAGR of 7.6%.
The drug-eluting stents segment is growing the fastest, with a CAGR of 8.1%.
The ambulatory surgical centers/outpatients segment is slated to grow at 7.9% CAGR during the study period.
Key drivers include rising PAD incidence, aging populations, diabetes prevalence, and innovations in stent technologies.
Top players include Medtronic Plc, Cardinal Health, Inc., B. Braun Melsungen AG, and Boston Scientific Corporation.
Explore Similar Insights
Peripheral Vascular Stent Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
